Amylyx Pharmaceuticals, Inc.
(AMLX - NASDAQ)
16,88 USD
📋 Profilo Aziendale

Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.

|